2HUANG B R. A brief introduction of the EGF application [ J ]. Bas-ic Clin Med, 1991, 1:7-9.
3WILSON S ., LLOYD S A. Epidermal growth factor and its recep-tor, basic fibroblast growth factor, transforming growth factor beta -1,and interleukin - 1 alpha meBsenger RNA production in humancomeal endothelial cells[ J]. Invest Ophthalmol Vis Sci, 1991, 32(10): 2747 -2756.
4COHEN S,SAVAGE C R Jr. Recent studies on the chemistry andbiology of epithelial growth factor [ J ]. Recent Prog Horm Res,1974,30(0) : 551 -574.
5WU Z Z,TANG Y, FANG H G, et al. Decellularized scaffolds con-taining hyaluronic acid and EGF for promoting the recovery of skinwounds[J]. J Mater Sci: Mater Med, 2015, 26( 1) *5322.
6HUANG P, XU X J, WANG L Y,et al. The role of EGF - EGFRsignalling pathway in hepatocellular carcinoma inflammatory micro-environment [J]. J Cell Mol Med,2014, 18(2) : 218 -230.
7CLAPERON A, MERGEY M, NGUYEN HO - BOULDOIRES T H,et al. EGF/EGFR axis contributes to the progression of cholangio-carcinoma through the induction of an epithelial - mesenchymal tran-sition [J]. J Hepatol, 2014,61 (2) ; 325 -332.
